ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ENDRA Life Sciences's revenue for the twelve months ending Dec 31, 2019 was $0, down 100.0% year over year. For fiscal 2020 it was $0. The highest annual figure on record is $515.58K in fiscal 2016.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $6.17K | -98.2% |
| FY2017 | Dec 31, 2017 | $351.62K | -31.8% |
| FY2016 | Dec 31, 2016 | $515.58K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $6.17K | – |
| Q4 FY2017 | Dec 31, 2017 | $6.85K | -98.7% |
| Q3 FY2017 | Sep 30, 2017 | $287.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $57.77K | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $515.58K | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?